Google
×
Kisqali is a pill used to treat hormone receptor-positive, HER2-negative breast cancer. If you were diagnosed with certain types of hormone receptor-positive, HER2-negative breast cancer, your doctor may prescribe Kisqali (chemical name: ribociclib) in combination with a hormonal therapy medicine.
Sep 18, 2024
People also ask
Learn about KISQALI, a treatment option for HER+, HER2- early breast cancer (eBC) and metastatic breast cancer (mBC). See full Prescribing and Safety Info.
Taking KISQALI + hormone therapy · 600 mg (three 200-mg pills) orally, once a day · With or without food · 3 weeks on, followed by 1 week off ...
KISQALI is indicated for the treatment of adults with HR-positive, HER2-negative advanced or metastatic breast cancer in combination with: • an aromatase ...
Kisqali - As bulas disponibilizadas neste portal destinam-se unicamente à consulta e referem-se às versões aprovadas junto à ANVISA.
Sep 30, 2024 · Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes Kisqali side effects, interactions and ...
KISQALI is given as 600 mg (3 x 200-mg tablets) orally, once daily (3 weeks on, 1 week off) with either1: · Patients should continue treatment until disease ...
KISQALI® is indicated in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone ...
A clipboard with a bar graph clipped to it. Experience targeted treatment proven to help people with your type of cancer live longer. KISQALI can give you more ...
The recommended dose of KISQALI is 600 mg (three 200 mg film-coated tablets) taken orally, once daily for 21 consecutive days followed by 7 days off treatment ...
Patients: Learn About Ways You May Be Able To Save On Your KISQALI® Prescription. Patients, Learn About KISQALI® Tablets And What It Treats. Talk To Your Doctor. Download Materials. Patient Resources.
HCPs: View The Video Library For Clinical Data And More KISQALI® Info At The Official Site. Data Like You've Never Seen Before. View Efficacy Results From KISQALI® Clinical Trials. Dosing Info. Safety Profile. Patient Resources.